DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

References

Bruix J. et al.
Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies.

J Hepatol 2017;
67: 999-1008

Download Bibliographical Data

Access:
Access: